An Exploratory, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, and Efficacy of Arbaclofen in Subjects with 16p11.2 deletion (Subaward)
Grant
Overview
administered by
sponsor award ID
- RFMH 251486-01
Affiliation
contributor
- Tang, Karen Principal Investigator (Subaward) 2024 - 2025